CNS Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-0.45-0.020.03
Price/Sales ratio
6.673.801.84
Earnings per Share (EPS)
$-12.2$-254.5$150

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-142.78K-10.16K-16.75K-3.10K-1.23K-213.96-0.25-0.03-9.93K
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-1.28M-136.85K8.54K2.10K2.70K401.85-1.070.112.40K
Price/Cash Flow ratio
-669.99K-104.93K-18.28K-4.01K-1.32K-309.55-0.33-0.08-11.14K
Price/Free Cash Flow ratio
-669.99K-104.93K-18.18K-4.00K-1.32K-309.42-0.33-0.08-11.09K
Price/Earnings Growth ratio
N/A-7.79352.44-21.681.48K6.250.00-0.00165.37
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
235.34%-0.63%-1.09%-0.03%-0.06%-0.04%N/AN/A-0.56%
Return on Assets
-324.59%-1081.74%-49.00%-59.65%-165.51%-117.01%-1108.33%-247.00%-112.58%
Return On Equity
899.45%1345.69%-51.00%-67.80%-218.90%-187.80%425.33%-230.33%-143.35%
Return on Capital Employed
367.49%160.52%-50.42%-67.78%-211.83%-187.72%425.64%-149.61%-108.69%
Liquidity Ratios
Current Ratio
N/AN/A25.388.13N/AN/AN/A6.994.06
Quick Ratio
0.730.4725.388.133.502.550.255.646.89
Cash ratio
0.500.2223.287.362.342.040.085.646.50
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A54.04K31.12K55.33K114.31K514.93KN/A43.23K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.750.46N/A0.020.040.030.170.120.07
Debt Equity Ratio
-2.08-0.57N/A0.030.050.05-0.060.140.01
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
1.92-1.36N/A0.030.050.04-0.07N/A0.04
Interest Coverage Ratio
N/AN/A-86.65-2.89KN/AN/AN/A2.74K-1.49K
Cash Flow to Debt Ratio
-0.92-2.26N/A-16.65-34.91-25.75-47.00N/A-8.32
Company Equity Multiplier
-2.77-1.241.041.131.321.60-0.381.141.08
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
-0.92-2.26N/A-16.65-34.91-25.75-47.00N/A-8.32
Short Term Coverage Ratio
-0.92-2.26N/A-16.65-34.91-25.75-47.00-292.64-25.78
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A